StonvexLoading…
StonvexStonvexStonvexCore line items from RVP's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $38.27M | $33.05M | $43.60M | $94.82M |
Operating Income | $-21.18M | $-21.11M | $-11.49M | $-852.98K |
Net Income | $-12.57M | $-11.89M | $-7.01M | $5.08M |
EPS (Diluted) | $-0.43 | $-0.40 | $-0.24 | $0.15 |
Total Assets | $142.63M | $160.72M | $179.67M | $195.67M |
Total Liabilities | $68.26M | $73.55M | $80.38M | $89.13M |
Cash & Equivalents | $2.59M | $4.24M | $12.67M | $19.72M |
Free Cash Flow OCF − CapEx | Not available | $-13.00M | $1.91M | $-61.95K |
Shares Outstanding | 29.94M | 29.94M | 29.94M | 29.94M |